JAK2 contributes to the intrinsic capacity of primary hematopoietic cells to respond to stem cell factor.

Objective: Stem cell factor (SCF) is the ligand for the receptor tyrosine kinase (RTK) Kit. The literature contains conflicting reports regarding the capacity of SCF to activate JAK2. Previous work has addressed this controversial issue using biochemical approaches.